Spinal Simplicity earned the FDA’s 510(k) clearance for the Freedom decompression system, according to an April 23 news release.
The minimally invasive system is designed for lumbar spinal stenosis and introduces enhanced instrumentation to improve procedural precision and efficiency.
“Freedom DS was designed with precision and purpose,” Todd Moseley, CEO of Spinal Simplicity said in the release. “Every instrument is thoughtfully engineered to enhance control, helping physicians work more efficiently. Most importantly, this expands our ability to treat the right patient with the right solution, all rooted in our mission to put patients first and help them get their freedom back.”
The system will be available in a phased limited market release, and a full commercial launch is expected in 2026.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
